Raymond E. Cabillot Sells 6,931 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 6,931 shares of the business’s stock in a transaction on Tuesday, January 21st. The stock was sold at an average price of $45.22, for a total value of $313,419.82. Following the transaction, the director now owns 337,752 shares of the company’s stock, valued at $15,273,145.44. This trade represents a 2.01 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.

Pro-Dex Stock Performance

Shares of NASDAQ PDEX opened at $41.86 on Friday. Pro-Dex, Inc. has a 1 year low of $16.18 and a 1 year high of $59.60. The firm has a market cap of $136.46 million, a P/E ratio of 27.18 and a beta of 0.56. The stock has a fifty day moving average price of $47.99 and a two-hundred day moving average price of $33.50. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.94 and a current ratio of 3.41.

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. Ascendiant Capital Markets lifted their price objective on shares of Pro-Dex from $30.00 to $52.00 and gave the company a “buy” rating in a research note on Monday, November 11th. StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 14th.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Ritholtz Wealth Management acquired a new stake in Pro-Dex in the 4th quarter valued at about $572,000. JPMorgan Chase & Co. raised its holdings in shares of Pro-Dex by 2.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 24,790 shares of the medical instruments supplier’s stock worth $740,000 after purchasing an additional 529 shares in the last quarter. Geode Capital Management LLC lifted its stake in Pro-Dex by 9.1% during the third quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock valued at $819,000 after purchasing an additional 2,296 shares during the last quarter. FMR LLC boosted its holdings in Pro-Dex by 34.9% during the third quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after buying an additional 1,028 shares in the last quarter. Finally, Bard Associates Inc. grew its position in Pro-Dex by 17.6% in the third quarter. Bard Associates Inc. now owns 13,596 shares of the medical instruments supplier’s stock worth $406,000 after buying an additional 2,031 shares during the last quarter. Institutional investors own 15.28% of the company’s stock.

Pro-Dex Company Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.